← Papers · Paper 32 — Psychedelic Therapy · MoreRight License v1.1 → Apache 2.0, Feb 2030

The Dissolution Void

Void Architecture in Psychedelic Therapy

Opacity2/3██░
Responsiveness2/3██░
Coupling2/3██░
Void Index7/12High (therapeutic) / Low (constrained)
Péclet NumberPe=3.8Phase II-III (therapeutic)

The Dissolution Void: Void Architecture in Psychedelic Therapy

Paper 32 — Psychedelic Therapy · v1.0 · February 2026

Applies the Void Framework to psychedelic-assisted therapy. Unique feature: the therapy deliberately induces temporary dissolution of the ego boundary — a controlled void state used therapeutically. The void is the mechanism, not the harm. Oregon and MAPS protocols as constraint implementations.

Platform Scores — Psychedelic Therapy

Void index across 6 platforms, scored on the three-dimension framework (0–12).

Platform Score Void Load
Underground Retreat (unregulated) 10/12
Ketamine Clinic (commercial) 8/12
MAPS Protocol (clinical trial) 4/12
Oregon Psilocybin (regulated) 4/12
FDA-Approved MDMA Protocol 3/12
Integration Therapy Only (Constraint) 2/12

Read the Full Paper

Complete methodology, empirical data, falsifiable predictions, and kill conditions.

Full Paper on Zenodo All Papers Framework Overview

Paper 32 · v1.0 · February 2026 · MoreRight License v1.1 → Apache 2.0, Feb 2030 · 10.5281/zenodo.18718975